The France-based vaccine company Valneva SE has appointed Juan Carlos Jaramillo as chief medical officer, effective 1 October, to lead the company’s portfolio of preventive treatments against Lyme disease, chikungunya and SARS-COV-2. Dr Jaramillo will succeed Wolfgang Bender who is retiring.
Dr Jaramillo has worked in a management capacity at GlaxoSmithKline Plc, Grünenthal GmbH and Daiichi-Sankyo Company Ltd.
Valneva announced the appointment on 6 August 2020.
Copyright 2020 Evernow Publishing Ltd